Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-08

Clinical Trial Update: Effect Of Semaglutide In Coronary Atheroma Plaque [Phase 3]

View source ↗

Summary

Phase 3 trial update investigating the effect of semaglutide on coronary atheroma plaque in patients with coronary atherosclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • semaglutide (semaglutide)

Snippet

Sponsor: Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León | Conditions: Atheroscleroses, Coronary | Phase 3 | Status: UNKNOWN